Takeda Pharmaceutical is stocking up its rare disease drug pipeline, reaching a deal for global rights to a Protagonist Therapeutics drug in late-stage development for the treatment of the rare blood ...
An extensive test of the Benchmade Protagonist fixed blade evaluating durability, balance, and field reliability.